Polymorphisms in the von Willebrand factor gene are not associated with proliferative retinopathy in non-insulin-dependent diabetes mellitus

Ophthalmic Research

Volumn 34, Issue 5, 2002, Pages 327-330

  Beránek, Michal ^a   Kaňková, Kateřina ^a   Kolář, Petr ^b   Znojil, Vladimír ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Genetic polymorphism; Non insulin dependent diabetes mellitus; Proliferative retinopathy; Von Willebrand factor

Indexed keywords

ENDONUCLEASE; VON WILLEBRAND FACTOR;

ADULT; AGED; ALLELE; ARTICLE; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RESTRICTION MAPPING; RISK; STATISTICAL SIGNIFICANCE;

AGED; ALLELES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VON WILLEBRAND FACTOR;

EID: 0036967789     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065604     Document Type: Article

References (10)

1. Lorenzi M, Cagliero E: Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes 1991;40:653-659.
2. Ruggeri ZM, Ware J: The structure and function of von Willebrand factor. Thromb Haemost 1992;67:594-599.
3. Fujiwara Y, Tagami S, Kawakami Y: Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy. J Atheroscler Thromb 1998;5:21-28.
4. Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY: Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: Relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 2000;41:2115-2119.
5. Harvey PJ, Keightley AM, Lam YM, Cameron C, Lillicrap D: A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. Br J Haematol 2000;109:349-353.
6. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D: Variation at the von Willebrand factor (vWf) gene locus is associated with plasma vWf:Ag levels: Identification of three novel single nucleotide polymorphisms in the vWf gene promoter. Blood 1999;93:4277-4283.
7. Lacquemant C, Gaucher C, Delorme C, Chatellier G, Gallois Y, Rodier M, Pasa P, Balkau B, Mazurier C, Marre M, Froguel P: Association between high von Willebrand factor levels and the Thr789Ala vWf gene polymorphism but not with nephropathy in type I diabetes. Kidney Int 2000;57:1437-1443.
8. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs: An extension of the modified Airlie House classification. ETDRS Report No 10. Ophthalmology 1991;98:786-806.
9. Minekura H, Kumagai T, Kawamoto Y, Nara F, Uchida K: 4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun 2001;282:557-561.
10. Heywood DM, Mansfield MW, Grant PJ: Levels of von Willebrand factor, insulin resistance syndrome, and a common vWf gene polymorphism in non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 1996;13:720-725.